Adverse Effects of Clove Tea
Clove tea lacks sufficient safety data in humans, particularly regarding bleeding risk, hypoglycemia in diabetics, and use during pregnancy/breastfeeding, warranting extreme caution in these populations.
Bleeding Risk
- Clove contains eugenol and related compounds that may have anticoagulant properties, theoretically increasing bleeding risk in individuals with bleeding disorders or those taking anticoagulant medications 1
- Patients on antiplatelet therapy (aspirin) or anticoagulants (warfarin, direct oral anticoagulants) should avoid clove tea due to potential additive bleeding effects, similar to precautions with other herbal products 2
- Those scheduled for surgery should discontinue clove tea at least 2 weeks prior due to theoretical bleeding complications 2
Hypoglycemic Effects in Diabetes
- Clove extracts demonstrate significant hypoglycemic activity through PPAR-γ activation, which could potentiate the effects of diabetes medications and cause dangerous hypoglycemia 1
- Active compounds (dehydrodieugenol and dehydrodieugenol B) stimulate glucose-lowering mechanisms that may be additive with metformin, sulfonylureas, or insulin 1
- Diabetic patients consuming clove tea require more frequent blood glucose monitoring and potential medication dose adjustments to avoid hypoglycemic episodes 2, 1
- The hypoglycemic effect is unpredictable due to variable concentrations of active compounds in herbal preparations 1
Pregnancy and Breastfeeding
- Clove tea should be avoided during pregnancy due to lack of safety data and theoretical risks to fetal development 2
- No human studies establish the safety of clove consumption during pregnancy, and the active compounds' placental transfer is unknown 2
- Breastfeeding mothers should avoid clove tea as excretion into breast milk and effects on infants are completely unstudied 2
- Pregnant women with gestational diabetes face compounded risk from unpredictable hypoglycemic effects 2, 3
Gastrointestinal Effects
- Herbal teas, including those containing clove, have been associated with severe gastrointestinal complications including peptic ulcer disease and gastrointestinal bleeding 4
- A documented case report describes life-threatening duodenal ulceration with hemorrhagic shock following herbal tea consumption 4
- Patients with pre-existing peptic ulcer disease or gastroesophageal reflux should avoid clove tea 4
Hepatotoxicity Risk
- While specific data on clove tea hepatotoxicity is limited, concentrated herbal extracts carry documented risk of liver damage 5
- Patients with pre-existing liver disease (cirrhosis, hepatitis) should avoid clove tea due to unknown hepatic metabolism and potential for drug-induced liver injury 2, 5
- Monitoring liver function tests should be considered in patients consuming clove tea regularly 5
Drug Interactions
- Clove tea may interact with multiple medication classes due to its bioactive compounds, though specific interaction data is lacking 5, 4
- Theoretical interactions exist with anticoagulants, antiplatelet agents, diabetes medications, and potentially cytochrome P450-metabolized drugs 2, 5
- Healthcare providers must specifically inquire about herbal tea consumption during medication reconciliation 4
Caffeine-Related Effects (if combined with traditional tea)
- If clove is combined with black or green tea, caffeine-related adverse effects apply 6
- Pregnant women should limit total caffeine intake to 200-300 mg daily (approximately 4-6 cups maximum) 6
- Healthy adults should stay below 400 mg caffeine daily (approximately 8-10 cups of tea) to avoid agitation, anxiety, and sleep disturbance 6
Critical Caveats
- The absence of rigorous human safety studies for clove tea means adverse effects may be underreported and unrecognized 7, 5, 4
- Herbal products marketed as "natural" are not subject to the same safety testing as pharmaceuticals, creating significant knowledge gaps 4
- Concentration of active compounds varies dramatically between preparations, making dose-response relationships unpredictable 5, 1
- Patients often fail to disclose herbal product use to healthcare providers, increasing risk of unrecognized adverse effects and drug interactions 4